Denver, Colorado, USA
Palo Alto, California, USA
Clinical Trials
Showing 1167 Clinical Trials-
Ketamine
Not Applicable
Completed
-
Trial Comparing the Effects of Xyrem (Sodium Oxybate) With Placebo for the Treatment of Fibromyalgia
Start Date: July 2022 Updated: January 2012
Los Angeles, California, USA
West Palm Beach, Florida, USA
Miami, Florida, USA
Portland, Oregon, USA
San Antonio, Texas, USA
Scottsdale, Arizona, USA
Durham, North Carolina, USA
Seattle, Washington, USA
Lexington, Kentucky, USA
Oklahoma City, Oklahoma, USA
Duncansville, Pennsylvania, USA
Raleigh, North Carolina, USA
Beverly Hills, California, USA
Shreveport, Louisiana, USA
Springfield, New Jersey, USA
Lenoir, North Carolina, USA
Middlebrook Heights, Ohio, USA
Katy, Texas, USA
Sandy, Utah, USA
Renton, Washington, USAGHB
Phase 2
Completed
-
Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder
Start Date: July 2022 Updated: May 2022
Madison, Wisconsin, USAPsilocybin
Phase 1
Not yet recruiting
-
Food Effects on Bioavailability of MDMA in Healthy Volunteers
Start Date: July 2022 Updated: May 2022
Knoxville, Tennessee, USAMDMA
Phase 1
Not yet recruiting
-
Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study
Start Date: July 2022 Updated: June 2022
Copenhagen, DenmarkPsilocybin
Phase 2
Not yet recruiting
-
Acute Effects of R- and S-MDMA in Healthy Subjects
Start Date: June 2022 Updated: March 2022
MDMA
Phase 1
Not yet recruiting
-
Effects of Psilocybin in Post-Treatment Lyme Disease
Start Date: June 2022 Updated: June 2022
Baltimore, Maryland, USAPsilocybin
Phase 1
Not yet recruiting
-
MDMA in Subjects With Moderate Hepatic Impairment and Subjects With Normal Hepatic Function
Start Date: June 2022 Updated: May 2022
San Francisco, California, USA
Knoxville, Tennessee, USAMDMA
Phase 1
Not yet recruiting
-
Preoperative Ketamine and Perioperative Depression
Start Date: June 2022 Updated: March 2022
Chicago, Illinois, USAKetamine
Phase 4
Not yet recruiting
-
Adjuvant Low-dose Ketamine in Pediatric Sickle Cell Vaso-occlusive Crisis
Start Date: June 2022 Updated: April 2021
Oakland, California, USAKetamine
Phase 2
Completed